There are too many lives at stake to give up. We can and must preserve antibiotics--the future of modern medicine depends upon it.

I applaud you for organizing this hearing and commend all the leaders in this room for giving voice to the dire situation of antibiotic resistance.

it is good to hear of the collaboration that is occurring between the public and private sectors.

I hope we will discuss today another approach to getting new antibiotics on the market.

I would like to ask unanimous consent that a statement prepared by Congresswoman Louise Slaughter be included in the record.

You have done a wonderful job at the FDA, and your responses to questions from both sides of the aisle have been very, very thoughtful.

I have a bill that would finally give the public access to this information, H.R. 820, the DATA Act.

So tell us how to change this economic model. You talked about that in your presentation.

We want to make sure they get a profit so that we want to guarantee we could take their investment, guarantee a certain percentage, and say that is how much the government will pay you.

I think it is essential that the drug bear a prominent statement describing the abbreviated pathway by which it came to market.

Last Congress we passed the GAIN Act to provide new incentives for the development of important antibiotics.

We have given tax credits. We want to shorten the time at FDA to get this review done as quickly as possible to get the drug out there.

I don't think Mr. Outterson or I thought or would want anybody to believe that we thought you don't need a profit and you don't need the private enterprise.

I believe a lot more in public investment because the pharmaceutical engineers are not going to make a lot of investment in this area when their research investments can result in a blockbuster drug.

Mr. Speaker, I yield myself the balance of my time. I thank the gentlewoman from the District of Columbia. Mr. Speaker, as I understand what the gentlelady has said is that, if we had passed a transportation bill, that would have provided…

Mr. Speaker, I yield such time as she may consume to the gentlewoman from the District of Columbia (Ms. Norton), who ought to be here rightfully as a full voting Member of the House, in my opinion.

Mr. Speaker, I won't take 25 minutes to rebut the statement that was just made. I yield myself 3 minutes. I am impressed by the statement we had from a man who is trying to educate, as he says, the American people in that Republicans worry…

Mr. Speaker, may I inquire as to how much time we have remaining? The SPEAKER pro tempore. The gentleman from California has 25 minutes remaining. The gentleman from Washington has 22 minutes remaining.